EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Twice-daily oral administration of a cannabidiol and cannabidiolic acid–rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile

Mariana Sosa-Higareda, David Sanchez-Migallon Guzman, Heather Knych, Alex Lyubimov, Alexander Zakharov, Beatriz Gomez, Hugues Beaufrère

American Journal of Veterinary Research · 2023

DOI: 10.2460/ajvr.22.11.0197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2023. Verfasst von Mariana Sosa-Higareda und 6 weiteren Autor:innen. Beteiligte Einrichtung: William T. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, CA. Hauptthemen laut MEDLINE: Cannabidiol, Amazona, Cannabis, Cannabinoids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To determine the pharmacokinetics of 8 cannabinoids and 5 metabolites after oral administration of single and multiple doses of a cannabidiol (CBD)-cannabidiolic acid (CBDA)–rich hemp extract to orange-winged Amazon parrots ( Amazona amazonica ) as well as to evaluate the extract’s adverse effects. ANIMALS 12 birds. PROCEDURES Based on pilot studies, a single-dose study based on 30/32.5 mg/kg of cannabidiol/cannabidiolic acid of a hemp extract was administered orally to 8 fasted parrots, and 10 blood samples were collected over 24 hours after administration. After a 4-week washout period, the hemp extract was administered orally to 7 birds at the previous dose every 12 hours for 7 days, and blood samples were collected at the previous time points. Cannabidiol, Δ9-tetrahydrocannabinol, cannabinol, cannabichromene, cannabigerol, cannabidiolic acid, cannabigerolic acid, Δ9-tetrahydrocannabinolic acid, and 5 specific metabolites were measured by liquid chromatography-tandem/mass-spectrometry, and pharmacokinetic parameters were calculated. Adverse effects and changes in the plasma biochemistry and lipid panels were evaluated. RESULTS Pharmacokinetic parameters for cannabidiol, cannabidiolic acid, Δ9-tetrahydrocannabinol, Δ9-tetrahydrocannabinolic acid, and the metabolite 11-hydroxy-9-tetrahydrocannabinol were established. For the multiple-dose study, cannabidiol/cannabidiolic acid mean C max was 337.4/602.1 ng/mL with a t max of 30 minutes and a terminal half-life of 8.6/6.29 hours, respectively. No adverse effects were detected during the multidose study. The predominant metabolite was 11-hydroxy-9-tetrahydrocannabinol. CLINICAL RELEVANCE Twice daily oral administration of the hemp extract based on 30 mg/kg/32.5 mg/kg of cannabidiol/cannabidiolic acid was well tolerated and maintained plasma concentrations considered to be therapeutic in dogs with osteoarthritis. Findings suggest different cannabinoid metabolism from mammals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolAmazonaCannabisCannabinoidsAnimalsDogsDronabinolAdministration, OralPlant ExtractsMammals

Substanzen

cannabidiolic acidCannabidiolDronabinolCannabinoidsPlant Extracts

Autor:innen und Institutionen

  • William T. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • K. L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California-Davis, Davis, CA.
  • Department of Pharmacology, Toxicology Research Laboratory, College of Medicine, University of Illinois, Chicago, IL.

Zitieren

APA

Sosa-Higareda, M., Guzman, D. S., Knych, H., Lyubimov, A., Zakharov, A., Gomez, B., & Beaufrère, H. (2023). Twice-daily oral administration of a cannabidiol and cannabidiolic acid–rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.22.11.0197

Vancouver

Sosa-Higareda M, Guzman DS, Knych H, Lyubimov A, Zakharov A, Gomez B, et al. Twice-daily oral administration of a cannabidiol and cannabidiolic acid–rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile. American Journal of Veterinary Research. 2023. doi:10.2460/ajvr.22.11.0197

BibTeX
@article{SosaHigareda2023,
  author = {Sosa-Higareda, Mariana and Guzman, David Sanchez-Migallon and Knych, Heather and Lyubimov, Alex and Zakharov, Alexander and Gomez, Beatriz and Beaufrère, Hugues},
  title = {Twice-daily oral administration of a cannabidiol and cannabidiolic acid–rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile},
  journal = {American Journal of Veterinary Research},
  year = {2023},
  doi = {10.2460/ajvr.22.11.0197}
}
Kostenlos starten →